=Abbott Labs (ABT) reported earnings on Wed 18 July 18 (b/o)

Abbott Labs beats by $0.02, reports revs in-line; guides Q3 EPS in-line; raises FY18 EPS guidance 

• Reports Q2 (Jun) earnings of $0.73 per share, excluding non-recurring items, $0.02 better than the Capital IQ Consensus of $0.71; revenues rose 17.0% year/year to $7.77 bln vs the $7.71 bln Capital IQ Consensus. On an organic basis, worldwide sales increased 8.0 percent.
• "All four of our businesses exceeded expectations and contributed to strong growth overall," said Miles D. White, chairman and chief executive officer, Abbott. "We forecast continued strong performance and are raising our full-year outlook despite recent currency shifts."
• Co issues in-line guidance for Q3, sees EPS of $0.73-0.75, excluding non-recurring items, vs. $0.74 Capital IQ Consensus Estimate.
• Co raises guidance for FY18, sees EPS of $2.85-2.91 (Prior $2.80-2.90), excluding non-recurring items, vs. $2.86 Capital IQ Consensus Estimate.